Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573566
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardiac ArrestKlinikum Klagenfurt am WörtherseeNot Yet RecruitingNot Applicable
NCT07573566Not Yet Recruiting
Not Applicable
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardia...Klinikum Klagenfurt am Wö...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07572981
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal WomenUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07572981Not Yet Recruiting
Not Applicable
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving H...University Hospital, Toul...
NCT07573657
Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Axillary Lymph Node Metastasis in Breast CancerBaicheng Central HospitalNot Yet Recruiting
NCT07573657Not Yet Recruiting
—
Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Ax...Baicheng Central Hospital
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573839
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature FusionShanghai Mental Health CenterRecruiting
NCT07573839Recruiting
—
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Us...Shanghai Mental Health Ce...
NCT07573540
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not Yet RecruitingNot Applicable
NCT07573540Not Yet Recruiting
Not Applicable
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alc...
NCT07571954
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center Prospective StudyiVascular S.L.U.Not Yet RecruitingNot Applicable
NCT07571954Not Yet Recruiting
Not Applicable
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center...iVascular S.L.U.
NCT07573020
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone LossMansoura UniversityCompletedNot Applicable
NCT07573020Completed
Not Applicable
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and M...Mansoura University
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07574086
Stratafix vs. PDS (Fascial Closure RCT)University of ArizonaNot Yet RecruitingNot Applicable
NCT07574086Not Yet Recruiting
Not Applicable
Stratafix vs. PDS (Fascial Closure RCT)University of Arizona
NCT07572331
Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face WrinklesNIRA Innovations Inc.CompletedNot Applicable
NCT07572331Completed
Not Applicable
Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 fo...NIRA Innovations Inc.
NCT07572552
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisTanta UniversityNot Yet RecruitingPhase 2
NCT07572552Not Yet Recruiting
Phase 2
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymar...Tanta University
NCT07572110
Project Independence: Randomized Controlled TrialUniversity of MiamiNot Yet RecruitingNot Applicable
NCT07572110Not Yet Recruiting
Not Applicable
Project Independence: Randomized Controlled TrialUniversity of Miami
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07572240
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy IndividualsRousselot BVBANot Yet RecruitingNot Applicable
NCT07572240Not Yet Recruiting
Not Applicable
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect o...Rousselot BVBA
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting2 (10%)
Completed2 (10%)
Enrolling by invitation1 (5%)
Withdrawn1 (5%)
not_applicable12 (60%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 11 (5%)